58 related articles for article (PubMed ID: 29162948)
1. Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients.
Dawood RM; El-Meguid MA; Shousha HI; Elsayed A; Nabeel MM; Yosry A; Abdelaziz A; Salum GM
Heliyon; 2022 Aug; 8(8):e10119. PubMed ID: 36033258
[TBL] [Abstract][Full Text] [Related]
2. Association of Polymorphisms in Inflammation Genes With the Prognosis of Advanced Non-Small Cell Lung Cancer Patients Receiving Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
Zhang X; Ye T; Li M; Yan H; Lin H; Lu H; Qi Z; Sheng H; He C
Front Oncol; 2022; 12():836117. PubMed ID: 35372081
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation.
Salum GM; El Meguid MA; Abelhafez TH; Medhat E; Abdel Aziz AO; Dawood R
J Genet Eng Biotechnol; 2021 Nov; 19(1):174. PubMed ID: 34757522
[TBL] [Abstract][Full Text] [Related]
4. Importance of genetic polymorphisms in liver transplantation outcomes.
Kelava T; Turcic P; Markotic A; Ostojic A; Sisl D; Mrzljak A
World J Gastroenterol; 2020 Mar; 26(12):1273-1285. PubMed ID: 32256016
[TBL] [Abstract][Full Text] [Related]
5. Donor polymorphisms of Rap1A rs494453 contribute to a higher risk of hepatocellular carcinoma recurrence following liver transplantation.
Zhang R; Wu J; Yang Y; Xia D; Li J; Quan H; Niu Z; Yang Y; Wu J
J Cancer; 2020; 11(10):3082-3088. PubMed ID: 32226523
[No Abstract] [Full Text] [Related]
6. Des-gamma-carboxy prothrombin in hepatocellular cancer patients waiting for liver transplant: a systematic review and meta-analysis.
Lai Q; Iesari S; Levi Sandri GB; Lerut J
Int J Biol Markers; 2017 Oct; 32(4):e370-e374. PubMed ID: 28561879
[TBL] [Abstract][Full Text] [Related]
7. Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.
Zhang T; Liu Y; Peng X; Fan J; Peng Z
Dis Markers; 2017; 2017():1754696. PubMed ID: 29162948
[TBL] [Abstract][Full Text] [Related]
8. Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Jiang Z; Jiang Q; Fang X; Wang P; Que W; Li H; Yu Y; Liu X; Wang C; Zhong L
BMC Cancer; 2021 May; 21(1):521. PubMed ID: 33964921
[TBL] [Abstract][Full Text] [Related]
9. The MTHFR polymorphism affect the susceptibility of HCC and the prognosis of HCC liver transplantation.
Wang C; Xie H; Lu D; Ling Q; Jin P; Li H; Zhuang R; Xu X; Zheng S
Clin Transl Oncol; 2018 Apr; 20(4):448-456. PubMed ID: 29185200
[TBL] [Abstract][Full Text] [Related]
10. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
[TBL] [Abstract][Full Text] [Related]
11. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
[TBL] [Abstract][Full Text] [Related]
12. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
[TBL] [Abstract][Full Text] [Related]
13. The clinical outcomes of patients with portal vein tumor thrombi after living donor liver transplantation.
Choi HJ; Kim DG; Na GH; Hong TH; Bae SH; You YK; Choi JY; Yoon SK
Liver Transpl; 2017 Aug; 23(8):1023-1031. PubMed ID: 28480517
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.
Fu YP; Yi Y; Huang JL; Jing CY; Sun J; Ni XC; Lu ZF; Cao Y; Zhou J; Fan J; Qiu SJ
Oncologist; 2017 May; 22(5):561-569. PubMed ID: 28438885
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
